Gunnar Juliusson
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 19
- Hematology top 2%
- Acute Myeloid Leukemia Research 11
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 5
-
- Lymphoma Diagnosis and Treatment 12
- Dermatology top 2%
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 5
-
- Acute Lymphoblastic Leukemia research 7
-
- Cancer therapeutics and mechanisms 4
In The Last Decade
Gunnar Juliusson
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 84
- Genetics 651
- Hematology 475
- Pathology and Forensic Medicine 663
- Dermatology 194
- Immunology 369
Countries citing papers authored by Gunnar Juliusson
This map shows the geographic impact of Gunnar Juliusson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Juliusson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Juliusson more than expected).
Fields of papers citing papers by Gunnar Juliusson
This network shows the impact of papers produced by Gunnar Juliusson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Juliusson. The network helps show where Gunnar Juliusson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gunnar Juliusson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2020 | 21 | |
| 6 | 2016 | 29 | |
| 7 | 2010 | 1 | |
| 8 | Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study | 2009 | 1 |
| 9 | Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: A high-resolution genomic screening in newly diagnosed patients | 2009 | 1 |
| 10 | A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity | 2008 | 16 |
| 11 | 2004 | 29 | |
| 12 | Low serum levels of soluble tumor necrosis factor receptors predict for response to thalidomide in advanced myeloma. | 2002 | 2 |
| 13 | Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT. | 2002 | 1 |
| 14 | V(a)3-21 gene utilizing chronic lymphocytic leukemias display restricted V lambda 2-14 gene usage and homologous CDR3s. | 2002 | 4 |
| 15 | No additional toxicity from cladribine (CdA) when given with cytosin arabinoside and idarubicin (CCI) as primary treatment of acute myeloid leukemia in elderly patients : Results from a randomized phase II-study from the leukemia group of middle Sweden (LGMS). | 2001 | 3 |
| 16 | Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience | 2000 | 12 |
| 17 | 2000 | 203 | |
| 18 | 1994 | 6 | |
| 19 | 1994 | 29 | |
| 20 | 1993 | 50 |
About Gunnar Juliusson
Gunnar Juliusson is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (10 papers), Acute Lymphoblastic Leukemia research (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Genetics (651 citations), Hematology (475 citations) and Pathology and Forensic Medicine (663 citations). Gunnar Juliusson has collaborated with scholars based in Sweden, Iceland and France. Frequent co-authors include Stig Lenhoff, Ingemar Turesson, Claes Malm, Fredrik Celsing, Magnus Adriansson, Gösta Gahrton, Wolfgang Knauf, Eva Cavallin‐Ståhl, Tom Wiklund and Anders Österborg. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.